Vein dilation system gains US FDA breakthrough device status
Amplifi Vascular has been granted breakthrough device designation by the US Food and Drug Administration (FDA) and category B assignment from the Centers for...
Study details immune response following pig kidney transplant
Research published in Nature Medicine describes the immune system’s reactions in detail in the first living patient to receive a genetically modified pig kidney...
Clinical trial of covered stent graft for dialysis access dysfunction completes enrolment
Solaris Endovascular has announced that the DEScover clinical trial has successfully completed enrolment.
DEScover is a prospective, multicentre clinical study evaluating the Solaris DE sirolimus-eluting,...
CorMedix announces interim results of study of DefenCath in haemodialysis patients with venous catheters
CorMedix Therapeutics has announced interim results for the ongoing real-world study being conducted in conjunction with US Renal Care’s use of DefenCath—a combined taurolidine...
